AbCellera Biologics Inc. ABCL Quick ratio
Quick ratio at other companies
Other financials
Where this comes from
Calculated from AbCellera Biologics Inc.’s reported figures.
Based on the most recent quarter.
The official record: AbCellera Biologics Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about AbCellera Biologics Inc.'s quick ratio.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is AbCellera Biologics Inc.'s quick ratio?
- AbCellera Biologics Inc. (ABCL) reported quick ratio of 13.9× in Q1 2026.
- How has AbCellera Biologics Inc.'s quick ratio changed year-over-year?
- AbCellera Biologics Inc.'s quick ratio increased by 36.9% year-over-year, from 10.1× to 13.9×.
- What is the long-term trend for AbCellera Biologics Inc.'s quick ratio?
- Over 5 years (2020 to 2025), AbCellera Biologics Inc.'s quick ratio has grown at a 7.4% compound annual growth rate (CAGR), from 7.9× to 11.2×.
- What does quick ratio mean?
- Current assets excluding inventory, divided by current liabilities at the quarter end (the 'acid-test'). A stricter liquidity measure that excludes the least-liquid current asset.